A Tricky Outlook, But Medtech Has Opportunities To Grow
Executive Summary
In Vivo editorial advisory board member and ZS principal Brian Chapman identifies the agenda-topping themes for medtech bosses.
You may also be interested in...
UK Medtech Strategy Before 2022 Year End, Government Promises
The UK government’s new procurement-and-beyond body housed in the DHSC says a medtech strategy could hit the presses before 2023. The medtech industry is cheered by promises of engagement.
Mike Mussallem: Inspiring People Is A Way Of Life
Edwards Lifesciences CEO Mike Mussallem has a unique and long-standing perspective of what the medtech industry should be and do. In over two decades, he has built the structural heart disease and critical care monitoring company into one of the global medtech industry’s most effective innovators.
Why Patient-Centered Care Has To Change
A typical word cloud for discussions around patient-centered care would feature: business model, digital health, financing, PPP, resources, data sharing, staffing and escalation of costs. But so many other words are missing, which is why patient-centricity risks getting stuck in its current incomplete form. What are medtechs to do?